Results

Total Results: 466 records

Showing results for "lung".
Users also searched for: lung cancer screening

161. Evidence Summary: Impaired Visual Acuity in Older Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/impaired-visual-acuity-screening-older-adults
     May 24, 2022 - excluded, the AREDS formulation with beta carotene was significantly associated with increased risk of lung … Almost all (91%) of the lung cancers occurred in former smokers. … and other evidence 74 indicating an association between use of beta carotene and increased risk of lung … Beta-carotene in multivitamins and the possible risk of lung cancer among smokers versus former smokers … The AREDS2 trial found the AREDS formulation with beta carotene associated with increased risk of lung

162. Evidence Summary: Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/menopausal-hormone-therapy-preventive-medication
     December 12, 2017 - Outcomes with no statistically significant reductions in risk included colorectal cancer, lung cancer … No statistically significant differences for cervical cancer, endometrial cancer, lung cancer, ovarian … therapy, no statistically significant differences were found for cervical cancer, endometrial cancer, lung … Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a … 80 ; 191 events in 19,371 women contribute to effect estimates (based on 2 RCTs 15 , 65 , 80 ) Lung

163. Archived: Evidence Summary: Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/menopausal-hormone-therapy-preventive-medication-december-2017
     December 12, 2017 - Outcomes with no statistically significant reductions in risk included colorectal cancer, lung cancer … No statistically significant differences for cervical cancer, endometrial cancer, lung cancer, ovarian … therapy, no statistically significant differences were found for cervical cancer, endometrial cancer, lung … Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a … 80 ; 191 events in 19,371 women contribute to effect estimates (based on 2 RCTs 15 , 65 , 80 ) Lung

164. Draft Research Plan: Enhanced Risk Assessment for Cardiovascular Disease: Coronary Artery Calcium Scoring | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/cardiovascular-disease-enhanced-risk-assessment-non-traditional-risk-factors
     April 25, 2024 -   Populations Adults without known cardiovascular disease Populations being screened for lung

165. Final Research Plan: Enhanced Risk Assessment for Cardiovascular Disease: Coronary Artery Calcium Scoring | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/cardiovascular-disease-enhanced-risk-assessment-non-traditional-risk-factors
     September 26, 2024 -   Populations Adults without known cardiovascular disease Populations being screened for lung

166. Archived: Final Research Plan: Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/menopausal-hormone-therapy-preventive-medication-december-2017
     October 22, 2015 - disease Stroke Thromboembolism Cancer (breast, colorectal, endometrial, ovarian, and nonsmall cell lung

167. USPSTF Clinician Summary of USPSTF Recommendation: Screening for Latent Tuberculosis Infection in Adults (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/nV4GCeHGsZrfKUWxo9_zZb
     April 01, 2023 - disease is an illness in which TB bacteria are multiplying and attacking a part of the body, usually the lungs

168. Screening for Obstructive Sleep Apnea (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/6h98_oWrAzFsnXsbjVqtQb
     April 25, 2022 - Click Here to Learn More About Sleep Apnea Screening for Sleep Apnea Sleep Apnea (National Heart, Lung

169. Draft Research Plan: Menopausal Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/menopausal-hormone-therapy-postmenopausal-women-primary-prevention-chronic-conditions
     February 18, 2021 - disease Stroke Thromboembolism Cancer (breast, colorectal, endometrial, ovarian, and nonsmall cell lung

170. Draft Research Plan: Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/menopausal-hormone-therapy-postmenopausal-persons-primary-prevention-chronic-conditions
     February 18, 2021 - disease Stroke Thromboembolism Cancer (breast, colorectal, endometrial, ovarian, and nonsmall cell lung

171. Evidence Summary: Hormone Therapy in Postmenopausal Persons: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary28/menopausal-hormone-therapy-preventive-medication
     November 01, 2022 - , 0.65-0.93]). 18 Outcomes without statistically significant findings included colorectal cancer, lung … statistically significant difference for cervical cancer, coronary heart disease, endometrial cancer, lung … Estrogen plus progestin and lung cancer: follow-up of the Women’s Health Initiative randomized trial. … Clin Lung Cancer . 2016;17(1):10-7.e1. doi:10.1016/j.cllc.2015.09.004 30. … Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a

172. Recommendation: Ovarian Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/ovarian-cancer-screening
     February 13, 2018 - screening for ovarian cancer, 6 there is a lack of evidence to support this. 7 Furthermore, the Prostate, Lung … Eligible participants were women aged 55 to 74 years without a previous diagnosis of lung, colorectal … Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer … The bimanual ovarian palpation examination in the Prostate, Lung, Colorectal and Ovarian cancer screening

173. Screening for Impaired Visual Acuity in Older Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/B73a4kJhxeaYyXK6gozbbY
     May 24, 2022 - significantly associated with increased risk of genitourinary events and beta carotene with increased risk of lung … Almost all (91%) of the lung cancers oc- curred in former smokers. … ) The AREDS2 trial found the AREDS formulation with beta carotene associated with increased risk of lung … cancer vs the AREDS formulation without beta carotene (2.0% vs 0.9%, P = .04); almost all (91%) of the lung … Beta-carotene in multivitamins and the possible risk of lung cancer among smokers versus former smokers

174. Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/uM5P-6XpsqVfEC2axGnZaD
     November 16, 2020 - anomalies) and complications in the offspring (including sudden infant death syndrome and impaired lung … American Lung Association; 1980. 28. … Outbreak of lung injury associated with the use of e-cigarette, or vaping, products. … Blount BC, Karwowski MP, Shields PG, et al; Lung Injury Response Laboratory Working Group. … Practice advisory: lung injury associated with e-cigarettes (“vaping”). Published October 2019.

175. Eighth Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/usptf-annual-report-congress-2018%20(1).pdf
     January 01, 2018 - Director National Heart, Lung, and Blood Institute (NHLBI) 20 | Eighth Annual Report to Congress … For example, in 2004, the USPSTF issued an I statement on screening for lung cancer. … • Of the four studies that the Task Force considered on the benefits of screening for lung cancer, … National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. … Reduced lung-cancer mortality with low-dose computed tomographic screening.

176. Screening for Ovarian Cancer: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/cHbBWNok76hRWKDXXm3R2_
     February 13, 2018 - UKCTOCS) were limited to postmenopausal women 45 years and older and 50 to 74 years31,33; the Prostate, Lung … .08f Abbreviations: CA-125, cancer antigen 125; HR, hazard ratio; NR, not reported; PLCO, Prostate, Lung … Food and Drug Administration; HR, hazard ratio; NA, not applicable; OR, odds ratio; PLCO, Prostate, Lung … Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: … Recruitment methods employed in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

177. Screening for Asymptomatic Carotid Artery Stenosis (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/Uz4eLCKkbkoT6Ea-QQUDmD
     August 31, 2020 - Stroke Prevention Carotid Artery Disease (Medline Plus) Carotid Artery Disease (National Heart, Lung

178. Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions: USPSTF Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/sTjqbTas6gW5pzaATpeBDn
     January 01, 2013 - evidence to determine whether hormone therapy has an adverse effect on the risk for developing or dying of lung … only therapy was found to be statistically significantly as- sociated with an increased incidence of lung … analysis reported that the use of combined therapy was associated with an increased risk for death from lung … No statistically significant increase in lung cancer mortality was seen with the use of oral estrogen … Lung cancer among postmenopausal women treated with estrogen alone in the Women’s Health Initiative randomized

179. Recommendation: Lipid Disorders in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/lipid-disorders-in-children-screening
     July 18, 2023 - The National Heart, Lung, and Blood Institute’s Expert Panel on Integrated Guidelines for Cardiovascular … events and are not age- and sex-specific. 1 Additional Tools and Resources The National Heart, Lung … Recommendations of Others The National Heart, Lung … National Heart, Lung, and Blood Institute.

180. Archived: Oral Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/oral-cancer-screening-2004
     February 04, 2004 - limit alcohol use in order to decrease their risk for oral cancer as well as heart disease, stroke, lung